Rei-Lin Kuo

Title: Rei-Lin Kuo: Innovator in Influenza A Virus Research

Introduction

Rei-Lin Kuo is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of virology, particularly in the development of vaccines and inhibitors for the Influenza A virus. With a total of 5 patents to his name, Kuo's work is pivotal in advancing medical science and public health.

Latest Patents

Kuo's latest patents focus on Influenza A virus vaccines and inhibitors. The inventions include compositions and methods related to the structure and function of the cellular polyadenylation and specificity factor 30 (CPSF30) binding site on the surface of the influenza A non-structural protein 1 (NS1). Specifically, these patents describe critical biochemical reagents, conditions for crystallization and NMR analysis, assays, and general processes for discovering, designing, and optimizing small molecule inhibitors of influenza A (avian flu) viruses. Additionally, they outline methods for creating attenuated influenza virus strains suitable for avian and human flu vaccine development.

Career Highlights

Throughout his career, Kuo has worked with esteemed institutions such as the University of Texas System and Rutgers, the State University of New Jersey. His research has significantly impacted the understanding and treatment of influenza viruses, contributing to the development of effective vaccines.

Collaborations

Kuo has collaborated with notable colleagues, including Robert M. Krug and Karen Y. Twu. Their combined expertise has furthered research in the field of virology and vaccine development.

Conclusion

Rei-Lin Kuo's innovative work in the realm of Influenza A virus research exemplifies the importance of scientific inquiry and collaboration. His contributions continue to influence the development of effective vaccines and treatments, showcasing the vital role of inventors in advancing public health.